FELIPE BATALINI FREITAS BATALINI FREITAS SILVA

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology SCOTTSDALE, AZ NPI 1306230867

General Payments — all program years on this page

$16,670.18

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 31
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $10,507.20 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $8,760.002
Travel and Lodging $1,015.384
Food and Beverage $381.828
Grant $350.001

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Gilead Sciences, Inc. $7,282.6912
Acerta Pharma LLC $3,224.513

By program year

Program yearAmountRecords
2019 $112.711
2022 $743.939
2023 $5,306.346
2024 $10,507.2015

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104724157 AstraZeneca Pharmaceuticals LP $2,740.00 10/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1105854198 AstraZeneca Pharmaceuticals LP $350.00 02/19/2024 Grant Undisputed 01/23/2026 View at CMS
1105855340 AstraZeneca Pharmaceuticals LP $134.51 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133599431 Gilead Sciences, Inc. $6,020.00 06/25/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133803948 Gilead Sciences, Inc. $24.72 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133803950 Gilead Sciences, Inc. $21.14 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133803952 Gilead Sciences, Inc. $28.86 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133803954 Gilead Sciences, Inc. $49.99 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133803956 Gilead Sciences, Inc. $52.38 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133803958 Gilead Sciences, Inc. $25.47 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133803960 Gilead Sciences, Inc. $44.75 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133866570 Gilead Sciences, Inc. $145.00 06/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1133866572 Gilead Sciences, Inc. $297.53 06/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1133866574 Gilead Sciences, Inc. $465.95 06/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1133866576 Gilead Sciences, Inc. $106.90 06/25/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.